Servier is extending its pact with Google Cloud as the French biopharma points to 60 examples of how generative artificial intelligence could improve its drug development processes.

The two companies initially signed a five-year pact in 2022 “aimed at deploying a robust technological structure within the Servier group to secure data and accelerate the deployment of initiatives such as AI.” But only two years in, Servier has already agreed to extend the collaboration for an additional five years.

Bayer has joined forces with Google Cloud to continue development of an artificial intelligence-powered platform to help radiologists diagnose patients quicker and more effectively and harness medical imaging data for R&D.

One of the most rapidly growing startups at the intersections of technology, artificial intelligence and radiology, Rad AI, announced today that it will be partnering with Google Cloud in scaling its efforts to improve clinical radiologists’ workflows and mitigate burnout.

Google Cloud launched two new AI-powered solutions that aim to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine. 

The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud’s director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.